Litts Drug Eruption & Reaction Database - Presented by CRC Press

Nothing else can remotely compare to it.Patricia Wong, MD, Stanford University Medical Centre


Log in
In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Continue
Menu
Login
  • Home
  • About About
    • About the Database
    • About the Book
    • Related Products
    • About Dr Litt
    • About Dr Shear
  • Alerts
  • Litt’s App
  • Contact Us
  • Help
  • Subscribe Subscribe
    • Individual Subscription
    • Institutional Subscription

Ciprofloxacin comment watch save
BreastfeedingGeriatric

  • TRADE NAMES: Ciflox; Ciloxan Ophthalmic (Alcon); Cimogal; Ciplox; Cipro (Bayer); Ciprobay Uro; Cipromycin; Ciproxin (Bayer); Italnik; Kenzoflex; Uniflox
  • INDICATIONS: Various infections caused by susceptible organisms, inhalational anthrax (post exposure)
  • CLASS: Antibiotic, Antibiotic; fluoroquinolone, Antibiotic; quinolone, Antimicrobial, CYP1A2 inhibitor, CYP3A4 inhibitor
  • HALF-LIFE: 4 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Agomelatine, Aminophylline, Amiodarone, Amitriptyline, Antacids, Antineoplastics, Arsenic, Artemether/Lumefantrine, BCG Vaccine, Bendamustine, Bepridil, Bismuth, Bismuth subsalicylate, Bretylium, Calcium salts, Citalopram, Clopidogrel, Clozapine, Corticosteroids, Cyclosporine, Dairy products, Dasatinib, Degarelix, Didanosine, Disopyramide, Dolasetron, Duloxetine, Dutasteride, Eluxadoline, Erlotinib, Erythromycin, Flibanserin, Insulin, Lanthanum, Lapatinib, Levofloxacin, Lumateperone, Magnesium salts, Meptazinol, Methotrexate, Methylxanthines, Mifepristone, Moxifloxacin, Mycophenolate, Neratinib, NSAIDs, Olanzapine, Olaparib, Opiod analgesics, Oral iron, Oxtriphylline, P-glycoprotein inhibitors, Pazopanib, Pentoxifylline, Phenothiazines, Phenytoin, Pirfenidone, Probenecid, Procainamide, Propranolol, QT prolonging agents, Quinapril, Quinidine, Rasagiline, Ropinirole, Ropivacaine, Sevelamer, Sotalol, St John's Wort, Strontium Ranelate, Sucralfate, Sulfonylureas, Telavancin, Telithromycin, Tizanidine, Tricyclic antidepressants, Typhoid Vaccine, Ubrogepant, Venetoclax, Vitamin K antagonists, Voriconazole, Vorinostat, Warfarin, Zinc, Ziprasidone, Zolmitriptan
  • See adverse reactions attributed to class:

    Antibiotic

    Antibiotic; fluoroquinolone

    Antibiotic; quinolone

    Antimicrobial

Fluoroquinolones are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants.

Fluoroquinolones may exacerbate muscle weakness in persons with myasthenia gravis.

Ciprofloxacin is chemically related to nalidixic acid.

SERIOUS ADVERSE REACTIONS INCLUDING TENDINITIS, TENDON RUPTURE, PERIPHERAL NEUROPATHY, CENTRIAL NERVOUS SYSTEM EFFECTS and EXACERBATION OF MYASTHENIA GRAVIS

See full prescribing information for complete boxed warning.

Please login to view the rest of this drug profile.

Page last updated 09/14/2024

Saved Searches Watched Drugs
Litt's app available free to subscribers

Search drug eruptions and reactions data anytime, anywhere

With full access to drug profiles, reactions and linked PubMed abstracts through your smart phone!

If you subscribe via your institution and do not have a personal login you will need to register on the website to create a login for the app.

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top
  • Help
  • Terms & Conditions
  • Privacy
  • Disclaimer
  • Contact us

© 2025 Taylor & Francis Group, LLC. All Rights Reserved.